LOCKHEED MARTIN CORP
For the period ended Sep 28, 2025. Filed Oct 21, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Oct 21, 2025
LMT$567.08-1.6%Stored close · as of Nov 6, 2026
Contents
Table of Contents
Form 10-Q
For the Quarterly Period Ended September 28, 2025
| Page | |||
|---|---|---|---|
| PART I. FINANCIAL INFORMATION | |||
| ITEM 1. · Financial Statements (Unaudited) | |||
| Consolidated Statements of Earnings for the Quarters and Nine Months Ended September 28, 2025 and September 29, 2024 | 3 | ||
| Consolidated Statements of Comprehensive Income for the Quarters and Nine Months Ended September 28, 2025 and September 29, 2024 | 4 | ||
| Consolidated Balance Sheets as of September 28, 2025 and December 31, 2024 | 5 | ||
| Consolidated Statements of Cash Flows for the Nine Months Ended September 28, 2025 and September 29, 2024 | 6 | ||
| Consolidated Statements of Equity for the Quarters Ended September 28, 2025 and September 29, 2024 | 7 | ||
| Consolidated Statements of Equity for the Nine Months Ended September 28, 2025 and September 29, 2024 | 8 | ||
| Notes to Consolidated Financial Statements | 9 | ||
| Report of Independent Registered Public Accounting Firm | 28 | ||
| ITEM 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 29 | |
| ITEM 3. | Quantitative and Qualitative Disclosures About Market Risk | 44 | |
| ITEM 4. | Controls and Procedures | 44 | |
| PART II. OTHER INFORMATION | |||
| ITEM 1. | Legal Proceedings | 47 | |
| ITEM 1A. | Risk Factors | 47 | |
| ITEM 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 48 | |
| ITEM 5. | Other Information | 48 | |
| ITEM 6. | Exhibits | 49 | |
| SIGNATURE | 50 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.